AddLife´s Group Management

The CEO shall manage the operations in accordance with the Companies Act and within the framework established by the Board of Directors. The work and role of the CEO and the division of duties between the Board of Directors and the CEO are detailed in a written set of instructions set out by the Board of Directors (“Instructions to the CEO”). The Board of Directors continuously evaluates the work of the CEO. In consultation with the Chairman of the Board, the CEO has prepared the information needed to make decisions at Board meetings and has presented reports and reasoned proposals for decisions. The CEO shall lead the work of the Group Management and make decisions in consultation with the other members of the Group Management. At the end of 2024, group management consisted of two people: Fredrik Dalborg, CEO and Christina Rubenhag, CFO. Group management regularly reviews operations in meetings chaired by the CEO.

Operational organisation
The Group's operational activities have been organized during the financial year into two business areas: Labtech and Medtech. Labtech consists of the business units Biomedical & Research and Diagnostics, and Medtech consists of the business units Hospital and Homecare. Operations are conducted through subsidiaries primarily in Europe, but also in Australia and China. Each operational subsidiary has a board of directors, where the subsidiary's CEO and management representatives from the business area are represented. Each subsidiary CEO reports to a business unit manager. The business unit manager reports to the CEO of AddLife AB.